Jove
Visualize
Contact Us

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Edwardsiella tarda infections in humans: a systematic review of reported cases and clinical outcomes.

BMC infectious diseases·2026
Same author

Molecular Insights and Antibiotic Resistance of <i>Proteus mirabilis</i> from Retail Meat Sources in Iran.

Food science & nutrition·2026
Same author

A novel Umezawaea tangerina endophyte reveals anti-colorectal cancer activity and a rich biosynthetic landscape.

Scientific reports·2026
Same author

A 25-year landscape of Escherichia coli vaccine development: systematic review of human clinical studies.

NPJ vaccines·2026
Same author

Virulence genes and antimicrobial resistance profiles of Klebsiella pneumoniae isolated from urinary tract infections.

BMC urology·2026
Same author

Artificial intelligence in immunotherapy: revolutionizing diagnostic and therapeutic applications in cancer and autoimmune diseases.

Clinical and experimental medicine·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 24, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K

Design a multi-epitope vaccine candidate against Acinetobacter baumannii using advanced computational methods.

Hana Heidarinia1, Elahe Tajbakhsh1, Yadollah Bahrami2,3,4

  • 1Department of Microbiology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.

AMB Express
|July 12, 2025
PubMed
Summary

A novel multi-epitope vaccine candidate targeting Acinetobacter baumannii outer membrane protein K (OmpK) was designed using in silico methods. This promising vaccine shows potential for eliciting robust immune responses against this challenging pathogen.

Keywords:
Acinetobacter baumanniiIn silicoMolecular dockingMolecular dynamicsMulti-epitopeOuter membrane protein K

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.1K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.6K

Related Experiment Videos

Last Updated: Jul 24, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.1K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.6K

Area of Science:

  • Immunology
  • Vaccine Development
  • Computational Biology

Background:

  • Acinetobacter baumannii is a major cause of hospital-acquired infections.
  • Antibiotic resistance in A. baumannii necessitates novel therapeutic strategies.
  • Outer membrane protein K (OmpK) is a key target for vaccine development.

Purpose of the Study:

  • To design and computationally evaluate a multi-epitope vaccine candidate against Acinetobacter baumannii.
  • To identify and select optimal T-cell and B-cell epitopes from OmpK.
  • To assess the immunogenic and structural properties of the designed vaccine construct.

Main Methods:

  • In silico prediction and selection of T-cell and B-cell epitopes.
  • Molecular docking of epitopes with Human Leukocyte Antigens (HLAs).
  • Multi-epitope construct design incorporating an adjuvant (β-defensin) and immunogenicity enhancer (PADRE).
  • Tertiary structure modeling and molecular dynamics (MD) refinement.
  • In silico analysis of physicochemical properties, immunogenicity, stability, and binding affinity to Toll-like Receptors (TLRs).

Main Results:

  • The designed multi-epitope construct demonstrated favorable immunogenicity and physicochemical properties.
  • In silico studies indicated favorable structural integrity, stability, and low toxicity.
  • The vaccine candidate showed potential for binding to Toll-like Receptors (TLRs), suggesting effective immune activation.
  • Predicted conformational B-cell epitopes and favorable cross-reactivity were observed.

Conclusions:

  • The in silico designed multi-epitope vaccine candidate targeting OmpK shows significant potential against Acinetobacter baumannii.
  • The construct possesses favorable immunogenic, structural, and binding properties for vaccine development.
  • Further in vitro and in vivo experimental validation is required to confirm efficacy.